Abstract
In order to detect T cells against several chronic myeloid leukaemia (CML)-associated antigens we used: (i) a novel T-cell assay [cytometric bead array (CBA)]; (ii) γ-interferon enzyme-linked immunoSPOT (γ-IFN-ELISpot); and (iii) tetramer staining in peripheral blood from CML patients. Peptide-specific cytokine release was detected by CBA in some patients, whereas standard γ-IFN-ELISpot and tetramer staining were negative in the vast majority of cases. In CBA, peptide-specific cytokine release was predominantly tumour necrosis factor-α, raising questions about the responding cells and their functional status. CBA appears to be a new useful tool for the detection of leukaemia-reactive T cells. © 2005 Blackwell Publishing Ltd.
Author supplied keywords
Cite
CITATION STYLE
Westermann, J., Van Lessen, A., Schlimper, C., Baskaynak, G., Coutre, P. L., Dörken, B., & Pezzutto, A. (2006). Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemia. British Journal of Haematology, 132(1), 32–35. https://doi.org/10.1111/j.1365-2141.2005.05844.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.